Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Other financing activities (2024)

Immunocore Holdings (IMCR) has disclosed Other financing activities for 1 consecutive years, with $1.1 million as the latest value for Q2 2024.

  • Quarterly Other financing activities changed N/A to $1.1 million in Q2 2024 from the year-ago period, while the trailing twelve-month figure was $1.1 million through Mar 2025, down 90.88% year-over-year, with the annual reading at $13.4 million for FY2024, N/A changed from the prior year.
  • Other financing activities hit $1.1 million in Q2 2024 for Immunocore Holdings, down from $12.2 million in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $12.2 million in Q1 2024 to a low of $1.1 million in Q2 2024.